Feasibility and Preliminary Effects of Implementing Acceptance and Commitment Therapy for Inpatients With Psychotic-Spectrum Disorders in a Clinical Psychiatric Intensive Care Setting.


Journal

Journal of cognitive psychotherapy
ISSN: 1938-887X
Titre abrégé: J Cogn Psychother
Pays: United States
ID NLM: 8806397

Informations de publication

Date de publication:
01 01 2020
Historique:
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 22 9 2021
Statut: ppublish

Résumé

The aim of this study was to adapt Acceptance and Commitment Therapy for Inpatients (ACT-IN) for implementation in a typical hospital setting to prepare for a larger clinical trial. The sample consisted of 26 inpatients diagnosed with psychotic-spectrum disorders. Using an open trial design, patients received individual and group ACT-IN sessions during their stay. We assessed the feasibility/acceptability of ACT-IN and preliminary changes on patient outcomes at baseline, discharge, and 4-month follow-up. We successfully recruited and retained participants as planned. Patients reported satisfaction with treatment, and routine hospital staff showed adoption and fidelity to the intervention. Relative to baseline, patients demonstrated significant improvements in symptoms and functioning across the 4-month follow-up. The current study shows that ACT-IN may be feasible and acceptable for inpatients with psychotic disorders in a psychiatric intensive care setting and should be tested in a future effectiveness-implementation trial.

Identifiants

pubmed: 32701478
pii: 34/1/80
doi: 10.1891/0889-8391.34.1.80
pmc: PMC8965771
mid: NIHMS1790902
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-96

Subventions

Organisme : NIMH NIH HHS
ID : R34 MH097987
Pays : United States

Informations de copyright

© Copyright 2020 Springer Publishing Company, LLC.

Références

N Z Med J. 2005 Nov 25;118(1226):U1752
pubmed: 16311610
Suicide Life Threat Behav. 2016 Dec;46(6):752-761
pubmed: 27038050
Br J Psychiatry. 2005 Oct;187:366-71
pubmed: 16199797
Adm Policy Ment Health. 2009 Jan;36(1):24-34
pubmed: 19104929
Br J Psychiatry. 2013 Mar;202(3):187-94
pubmed: 23457182
PLoS One. 2009 Dec 17;4(12):e8343
pubmed: 20020047
Psychiatr Serv. 2012 Jan;63(1):87-90
pubmed: 22227766
Psychother Psychosom. 2015;84(1):30-6
pubmed: 25547522
Br J Psychiatry. 2018 Aug;213(2):490-497
pubmed: 29941055
Schizophr Res. 2011 Oct;132(1):18-23
pubmed: 21764563
Schizophr Res. 2010 Aug;121(1-3):241-50
pubmed: 20541912
J Behav Ther Exp Psychiatry. 2016 Mar;50:257-63
pubmed: 26480469
Behav Res Ther. 2011 Dec;49(12):901-7
pubmed: 21975193
Schizophr Res. 2013 Oct;150(1):176-84
pubmed: 23954146
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Behav Ther. 2011 Dec;42(4):676-88
pubmed: 22035996
Behav Res Ther. 2012 Feb;50(2):110-21
pubmed: 22186135
Acta Psychiatr Scand. 2014 Dec;130(6):418-26
pubmed: 25230813
Clin Psychol Rev. 2016 Apr;45:183-92
pubmed: 27048980
Schizophr Res. 2008 Mar;100(1-3):60-9
pubmed: 18255269
Behav Res Ther. 2006 Mar;44(3):415-37
pubmed: 15893293
J Consult Clin Psychol. 2002 Oct;70(5):1129-39
pubmed: 12362963
Schizophr Res. 2017 May;183:143-150
pubmed: 27894822
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Annu Rev Med. 2009;60:393-403
pubmed: 18729730
Br J Psychiatry. 2017 Feb;210(2):140-148
pubmed: 27979820
Neuropsychopharmacology. 2003 Apr;28(4):773-7
pubmed: 12655324
Healthcare (Basel). 2017 May 05;5(2):
pubmed: 28475123
Psychol Res Behav Manag. 2014 Apr 28;7:137-45
pubmed: 24812527
Schizophr Bull. 2001;27(1):73-92
pubmed: 11215551
Arch Gen Psychiatry. 2007 Jan;64(1):19-28
pubmed: 17199051
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370
J Clin Psychiatry. 2016 Jun;77(6):764-71
pubmed: 27135986
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721

Auteurs

Brandon A Gaudiano (BA)

Alpert Medical School of Brown University.
Butler Hospital, Providence, RI, USA.

Stacy Ellenberg (S)

Binghamton University, Binghamton, NY, USA.

Barbara Ostrove (B)

Butler Hospital, Providence, RI, USA.

Jennifer Johnson (J)

Michigan State University, Flint, MI, USA.

Kim T Mueser (KT)

Boston University, Boston, MA, USA.

Martin Furman (M)

Alpert Medical School of Brown University.
Butler Hospital, Providence, RI, USA.

Ivan W Miller (IW)

Alpert Medical School of Brown University.
Butler Hospital, Providence, RI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH